Your browser doesn't support javascript.
loading
Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
Moody, M Anthony; Gao, Feng; Gurley, Thaddeus C; Amos, Joshua D; Kumar, Amit; Hora, Bhavna; Marshall, Dawn J; Whitesides, John F; Xia, Shi-Mao; Parks, Robert; Lloyd, Krissey E; Hwang, Kwan-Ki; Lu, Xiaozhi; Bonsignori, Mattia; Finzi, Andrés; Vandergrift, Nathan A; Alam, S Munir; Ferrari, Guido; Shen, Xiaoying; Tomaras, Georgia D; Kamanga, Gift; Cohen, Myron S; Sam, Noel E; Kapiga, Saidi; Gray, Elin S; Tumba, Nancy L; Morris, Lynn; Zolla-Pazner, Susan; Gorny, Miroslaw K; Mascola, John R; Hahn, Beatrice H; Shaw, George M; Sodroski, Joseph G; Liao, Hua-Xin; Montefiori, David C; Hraber, Peter T; Korber, Bette T; Haynes, Barton F.
Afiliação
  • Moody MA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA; Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: moody007@mc.duke.edu.
  • Gao F; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: feng.gao@dm.duke.edu.
  • Gurley TC; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Amos JD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Kumar A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Marshall DJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Whitesides JF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Xia SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Parks R; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Lloyd KE; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Hwang KK; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Lu X; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Bonsignori M; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Finzi A; Centre de Recherche du CHUM and Department of Microbiology, Infectology and Immunology, Université de Montréal, Montreal, QC H2X 0A9, Canada and Department of Microbiology and Immunology, McGill University, Montreal, QC H2X 1P1, Canada.
  • Vandergrift NA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Alam SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA; Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
  • Ferrari G; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
  • Shen X; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA.
  • Tomaras GD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
  • Kamanga G; University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
  • Cohen MS; Departments of Medicine, Epidemiology, Microbiology, and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Sam NE; Kilimanjaro Christian Medical Center, Moshi 25102, Tanzania.
  • Kapiga S; London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Gray ES; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.
  • Tumba NL; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.
  • Morris L; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.
  • Zolla-Pazner S; Department of Pathology, New York University School of Medicine, New York, NY 10010, USA; Veterans Affairs New York Harbor Healthcare System, New York, NY 10010, USA.
  • Gorny MK; Department of Pathology, New York University School of Medicine, New York, NY 10010, USA.
  • Mascola JR; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA.
  • Hahn BH; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Shaw GM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Sodroski JG; Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Liao HX; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Montefiori DC; Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
  • Hraber PT; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  • Korber BT; Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  • Haynes BF; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: hayne002@mc.duke.edu.
Cell Host Microbe ; 18(3): 354-62, 2015 Sep 09.
Article em En | MEDLINE | ID: mdl-26355218
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Seleção Genética / Anticorpos Anti-HIV / Linfócitos T CD4-Positivos / Proteína gp120 do Envelope de HIV / HIV-1 / Ligação Viral / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Seleção Genética / Anticorpos Anti-HIV / Linfócitos T CD4-Positivos / Proteína gp120 do Envelope de HIV / HIV-1 / Ligação Viral / Anticorpos Neutralizantes Idioma: En Ano de publicação: 2015 Tipo de documento: Article